Milind A. Phadnis, MS, PhD

Professional Background

Milind Phadnis is an Associate Professor in Department of Biostatistics & Data Science at the University of Kansas Medical Center. His methodological interests are in the field of Survival Analysis and Design of Clinical Trials. He has collaborated extensively with researchers from nephrology, stroke, neurology, oncology and many other areas. He is the co-director of the Biostatistics section of Investigator Initiated Trials supported by the Cancer Center at his university. He has also served as the site-PI for an American Heart Association grant and is a two-time winner of Biostatistics & Epidemiology Research Design award at his university. He teaches Masters and PhD level courses in Biostatistics to students in his department and also Service-level courses to students from other departments. He also won the Outstanding Graduate Teaching Award for the 2020-21 academic year.

• PhD, Biostatistics, University of Alabama-Birmingham, Birminbham, AL
• MS, Industrial Engineering, University of Alabama, Tuscaloosa, AL
• Other, Production Engineering, Fr. Conceicao Rodrigues College of Engineering, Mumbai, Maharashtra

• Association for Clinical and Translational Statisticians, Member, 2017 - Present
• Investigator Initiated Trials, Member, 2016 - Present
• University of Kansas Cancer Center, Member, 2015 - Present
• American Statistical Association, Member, 2010 - Present

---

• Wetmore James B, Phadnis Milind A, Mahnken Jonathan D, Ellerbeck Edward F, Rigler Sally K, Zhou Xinhua, Shireman Theresa I. 2014. Race, ethnicity, and state-by-state geographic variation in hemorrhagic stroke in dialysis patients.. Clinical Journal of the American Society of Nephrology, 9 (4), 756-763. https://cjasn.asnjournals.org/content/clinjasn/9/4/756.full.pdf
• Phadnis Milind A, Wetmore James B, Mayo Matthew S. 2017. A clinical trial design using the concept of proportional time using the generalized gamma ratio distribution.. Statistics in Medicine, 36, 4121-4140. https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.7421
• Phadnis Milind A, Wetmore James B, Shireman Theresa I, Ellerbeck Edward F, Mahnken Jonathan D. 2017. An ensemble survival model for estimating relative residual longevity following stroke: Application to mortality data in the chronic dialysis population.. Statistical Methods in Medical Research, 26 (6), 2667-2680. https://journals.sagepub.com/doi/pdf/10.1177/0962280215605107
• Phadnis Milind A, Mayo Matthew S. 2021. Sample size calculation for two-arm trials with time-to-event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions.. Biometrical journal, 63 (7), 1406-1433. https://doi.org/10.1002/bimj.202000043
• Sharma Priyanka, Abramson Vandana G, O'Dea Anne, Nye Lauren, Mayer Ingrid, Pathak Harsh B, Hoffmann Marc, Stecklein Shane R, Elia Manana, Lewis Sharon, Scott Jecinta, De Jong Jilliann A, Wang Yen Y, Yoder Rachel, Schwensen Kelsey, Finke Karissa, Heldstab Jaimie, LaFaver Stephanie, Williamson Stephen K, Phadnis Milind A, Reed Gregory A, Kimler Bruce F, Khan Qamar J, Godwin Andrew K. 2021. Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer.. Clinical Cancer Research, 27 (14), 3896-3904. https://doi.org/10.1158/1078-0432.ccr-20-4879
• Waleed Muhammad, He Jianghua, Phadnis Milind A. 2021. Some design considerations incorporating early futility for single-arm clinical trials with time-to-event primary endpoints using Weibull distribution.. Pharmaceutical Statistics, 20 (3), 610-644. https://dx.doi.org/10.1002/pst.2097
• Jain Nishank, Phadnis Milind A, Hunt Suzanne L, Dai Junqiang, Shireman Theresa I, Davis Clayton L, Mehta Jawahar L, Rasu Rafia S, Hedayati S Susan. 2021. Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis.. Kidney International Reports, 6 (9), 2381-2391. https://doi.org/10.1016/j.ekir.2021.06.031
• Saeed Anwaar, Park Robin, Dai Junqiang, Al-Rajabi Raed, Kasi Anup, Baranda Joaquina, Williamson Stephen, Saeed Azhar, Ripp Jacob, Collins Zachary, Mulvaney Kelly, Shugrue Molly, Firth-Braun Jeanette, Godwin Andrew K, Madan Rashna, Phadnis Milind, Sun Weijing. 2023. Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results. Cell Reports Medicine, 4 (2), 1-11. https://doi.org/10.1016/j.xcrm.2023.100916
• Sun Weijing, Veeramachaneni Nirmal, Al-Rajabi Raed, Madan Rashna, Kasi Anup, Al-Kasspooles Mazin, Baranda Joaquina, Saeed Anwaar, Phadnis Milind A, Godwin Andrew K, Olyaee Mojtaba, Streeter Natalie, Nagji Alykhan, Dai Junqiang, Williamson Stephen. 2023. A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma. Cancer Medicine, 12 (15), 16098-16107. https://pubmed.ncbi.nlm.nih.gov/37326317/
• Waleed Muhammed, He Jianghua, Phadnis Milind A. 2023. Sample size reestimation and Bayesian predictive probability for single-arm clinical trials with a time-to-event endpoint using Weibull distribution with unknown shape parameter. Journal of Biopharmaceutical Statistics, 34 (4), 469-487. https://doi.org/10.1080/10543406.2023.2234998